Effects of intraperitoneal injection of allogeneic lymphocytes on insulin secretion were studied in incubated pancreas slices from BALB/c mice. Injection of allogeneic lymphocytes from C57BL/ 6J (H2b) mice increased insulin secretion, both in basal and 11-mM glucose-stimulated conditions. This effect was only present when at least 5 X 106 or I X 10' cells were injected (in basal and stimulated conditions, respectively). Glucose-induced insulin secretion (33-27.5 mM) was significantly increased in pancreata from mice injected with allogeneic lymphocytes. No effect was observed when glucose was not included in the incubation medium. Intraperitoneal injection of Dextran 70 produced no change in glucose-elicited insulin secretion. There were no differences in glucagon and somatostatin (SRIF) secretion obtained from pancreas of mice injected with allogeneic or syngeneic lymphocytes. Injection of allogeneic cells increases insulin secretion (basal and both phases of 11 mM glucose-stimulated secretion). Puromycin significantly inhibited the second phase of insulin secretion. These results suggest that: (a) Injection of allogeneic lymphocytes raises both basal and glucose-stimulated insulin secretion. (b) This effect seems to be connected with the major histocompatibility complex, and to be related to the number of allogeneic cells injected. (c) Injection of allogeneic lymphocytes seems to sensitize the beta cell response to glucose stimulus. (d) Neither glucagon nor SRIF secretion are altered by alloantigen injection. (e) The stimulatory effect of allogeneic lymphocytes is related, at least in part, to insulin synthesis.
Introduction
Interaction between the endocrine and immune system is complex and the study of potentially critical factors needs multidisciplinary analysis.
Numerous findings support the existence of regulatory circuits between the immune and endocrine systems. Antigen injection into mice induces a rapid increase in gonadotropins blood levels, the pharmacological suppression of which results in a blockade of antibody synthesis and specific tolerance (1) .
Resting T lymphocytes have no insulin receptors, but they develop them de novo after nonspecific mitogen stimulation by Concanavalin A (2, 3) . Insulin provided to receptor-bearing lymphocytes increases intermediary metabolism above mitogen-stimulated levels (4) . Furthermore, insulin as well as other ligands, which increase intracytoplasmatic cyclic guanosine monophosphate, augment lymphocyte-mediated cytotoxicity (5) . These factors strongly suggest a physiological role for insulin in immunoregulation.
In a previous set of experiments, we found that sheep red blood cell injection into inbred mice caused an increase in insulin secretion from incubated pancreas slices (authors' unpublished data).
The following study was designed to investigate the response of mice endocrine pancreas to alloantigen injection.
Methods

Animal model
We used 6-9-wk-old male and female, fed inbred BALB/c, C57BL/KsJ, and C57BL/6J mice provided by the Instituto Nacional de Genetica M&dica (Buenos Aires).
Preparation ofcell suspensions
Cell suspensions were prepared by two methods: (a) The tissue (spleen) was submitted to a soft mechanical disruption in cold saline solution for homogenization; it was washed three times, and concentration was adjusted to 50 X 106 cells per milliliter, (b) In other experiments spleen lymphocytes were purified by centrifugation in a Ficoll-Hypaque gradient. No Experimental model Antigen injection. 10' spleen cells from BALB/c (H2d), C57BL/KsJ or C57BL/6J (H2b) mice resuspended in a volume of 0.2 ml were injected intraperitoneally into BALB/c mice. The animals were killed 30, 60, 120, and 300 min after injection and each mouse's pancreas was removed in order to be incubated as specified in "Incubation technique," below.
In a separate set of experiments, Dextran T70 (Pharmacia Fine Chemicals, Piscataway, NJ), a conventional soluble antigen, at a concentration of 50 or 500 ,g diluted in 0.2 ml saline, was injected intraperitoneally into BALB/c mice. The animals were killed 90 min after injection and each animal's pancreas was removed to be incubated as discussed in "Dynamics of insulin secretion," below.
Bidirectional lymphocytes culture (BALB/c vs. C3H). Purified lymphocytes suspensions were prepared from spleen cells by Ficoll-Hypaque gradient. After washing, they were resuspended at a concentration of I0' cells/ml in RPMI 1640 with 5% fetal calf serum and antibiotics, and cultured in plastic mignon tubes at 37'C for different time periods (Table  I) . Replicate cultures were pooled, centrifugated at 1,500 rpm for 10 min, and the supernatants were used without further manipulations. Dynamics ofinsulin secretion. 107 spleen cells from BALB/c or from C57BL/6J mice were injected intraperitoneally into BALB/c mice. The mice were killed 90 min after injection and pancreata were removed for Perifusion technique. The technique described by Burr et al. (7) was used. The perifusion medium and the procedure to obtain the slices of pancreas were similar to those described above. Glucose, 11 mM, used as stimulus for insulin secretion, was added to the perifusion medium at 3 min. The proteolytic effect on the hormonal secretion was avoided by using Trasylol in the buffer and by collecting the samples on 0.25 M EDTA in tubes at 4°C, which were immediately frozen at -20°C.
Hormonal dosage
Insulin. Insulin was determined by the method of Herbert et al. (8) modified by Cresto et al. (9) . The pork monoiodine insulin of high specific activity was labeled with 1251, separated by means of a starch preparative gel chromatography, and purified by passage through a Sephadex G-100 column. The rat standard insulin was obtained from Novo Research Laboratories (Denmark). The anti-insulin antibody proved to be sufficiently "nonspecific" to displace the labeled insulin b both the rat standard and our experimental insulin. This method allowed determination within 0.4-32 ng/ml range.
Glucagon. Glucagon was determined by the Serono Biodata Glucagon polyethylene glycol (PEG). Kit, Hypolab S.A. (Switzerland), batches 10727 and 10810. With minor modifications in the antiserum dilution, this method allowed determination within a 15-1,000 ng/ml range. (11) .
Somatostatin (SRIF
Results
Intraperitoneal injection of C57BL/6J (H2b) lymphocytes into BALB/c (H2d) mice significantly increased insulin secretion, both in basal (3.3 mM glucose) and stimulated (11 mM glucose) conditions. This rise was observed when the mice were sacrificed 30, 60, and 120 min after injection, but not when they were sacrificed 300 min after injection (Fig. 1) (Fig. 2) .
It can also be seen in Fig. 1 , that when BALB/c (H2d) mice were injected with lymphocytes from C57BL/KsJ (H2d) mice, there was no change in the amount of insulin secreted. Table III also shows that the stimulatory effect ofalloantigen injection on insulin secretion was not observed in a medium containing 0 mM glucose.
In our experimental conditions allogeneic lymphocyte injection did not modify glucagon secretion, either in basal or in both phases of 5.5 mM glucose/20 mM arginine-stimulated conditions, as can be observed in Table IV (the point at which the maximal value was attained, was considered representative of the first phase of glucagon release, generally at 5 min of perifusion; and the value occurring at 40 min as representative of the second phase).
Somatostatin secretion pattern, both in basal and glucosestimulated conditions, was not altered by the injection of allogeneic cells (Fig. 3) . Fig. 4 shows insulin secretion patterns stimulated with 11 mM glucose from perifused slices of pancreas of BALB/c mice injected with allogeneic or syngeneic lymphocytes. Injection of allogeneic lymphocytes induced a pattern ofbasal and stimulated hormone response, significantly higher than control. (Area under the curve in nanograms of secreted insulin per 100 mg of pancreatic tissue, X+SEM; pancreas of mice injected with allogeneic lymphocytes vs. pancreas of mice injected with syngeneic lymphocytes. Basal: minutes 1-3, 9.8±0.5 vs. 5.2±0.5, P < 0.001. In some groups Puromycin, 80 ,g/ml, was added to the penfusion medium. In all cases this drug was perifused during 30 min immediately before sample collection, and was then perifused for 40 min in each experiment. At the concentration used, Puromycin inhibits 95-99% of ['4Cjvaline incorporation into pancreatic proteins.
The second phase of insulin secretion induced by 11 mM glucose in pancreas from mice injected with allogeneic cells, is clearly inhibited by Puromycin (Fig. 5) Insulin secretion induced by different glucose concentrations from incubated pancreas slices of BALB/c mice sacrificed 90 min after syngeneic or allogeneic lymphocyte injection (mean±SEM; n = 6 in each group). w.t., wet tissue.
BALB/c mice were injected with allogeneic lymphocytes from C57BL/KsJ mice (which have the same H2 complex as the receptor but in a different genetic background), our experimental model showed no increase in insulin secretion. This suggests that the increase could be related to the major histocompatibility complex. ulus can increment portal hormonal levels with little or no change in peripheral insulin concentration (14, 15) . In our experimental arrangement, peripheral insulin levels were slightly altered but not enough (P NS) to induce any appreciable change on glycemic concentration. Reports on the immunohistochemistry and electron microscopy ofthe endocrine pancreas disclosed connections among a, fi, and i cells (16) . On the basis of this and other reports, the existence of interregulation among insulin, glucagon, and SRIF has been postulated (16) (17) (18) Constant pancreas stimulus with 11 mM glucose produces a biphasic insulin secretion pattern. The first phase represents the exocytosis of granules formed and aligned in the system of microtubules and microfilaments of the beta cell. The second phase, which is slower and more prolonged, is the result of the release of both accumulated granules and granules with insulin synthetized de novo (19) . Stimulation with allogeneic lymphocytes produced an increase in both insulin secretion phases. This seems to indicate that stimulus acts on both the fast and the slow insulin releasing pools. The second phase ofglucose-induced insulin secretion can be partially inhibited (20-30%) by protein synthesis inhibitors. For this reason it has been postulated that this provisionary phase is related to precursor synthesis (19) (20) (21) .
Since injection of allogeneic lymphocytes sensitized the second phase ofglucose-induced insulin secretion, the question that arises is whether this effect might be related to insulin synthesis or not. As can be seen in Figs. 5 and 6, Puromycin added to the perifusion medium significantly inhibited the second phase of the glucose-stimulated insulin secretion. Although indirectly, this showed that the increased sensitivity of the beta cell to glucose induced by allogeneic lymphocytes was related, at least in part, to insulin synthesis. Glucose at a 5.5-mM concentration caused only one phase insulin secretion. Alloantigen injection, in turn, modified not only the amount but also the pattern of 5.5 mM glucose-induced hormone secretion, substituting a monophasic by a biphasic profile. Incidentally, the change in the insulin secretion pattern caused by the injection of allogeneic lymphocytes, where 5.5 mM glucose is used as stimulus, was similar to that elicited by glibenclamide, sodium salicylate, or theophylline, all substances with previously reported stimulatory effects on cyclic AMP pancreatic levels (22) (23) (24) . Although any comment or tentative explanation would be, at'present, only speculative, these results could suggest that the increase in beta cell sensitivity to glucose caused by alloantigen injection might be mediated, at least in part, by an effect on cyclic AMP levels.
Insulin secretion by the pancreatic beta cell is regulated in both an immediate (nutrients, neurotransmitters, hormones) and a chronic (ontogenic, endocrine, and nutritional factors) fashion; that is to say, there is a multifactorial regulation for a single process of secretion (25, 26) . Our results suggest that the immune system should be considered among the insulin secretion regulatory factors. Up to now we do not know the characteristics of this hormonal response to antigenic stimulation. It may be that the immune interaction produces the release ofsome lymphokine or interleukin capable of stimulating the beta cell. Although the data obtained with the supernatants of bidirectional lymphocytes cultures seem to support a direct effect on the pancreas, they do not rule out that allogeneic lymphocytes might also induce the synthesis or release of nonspecific factor(s) from nonlymphoid tissues' that increase insulin secretion.
Regardless of whether these speculations prove correct, our study supplies new data that support the existence of an interrelation between insulin and the immune system. 
